Other Information
−Removed: During the three months ended November 1, 2024, no director or officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or a "non-Rule 10b5-1 trading arrangement," as such terms are defined in Item 408 of Regulation S-K.
+Added: During the three months ended May 2, 2025, no director or officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or a "non-Rule 10b5-1 trading arrangement," as such terms are defined in Item 408 of Regulation S-K.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
Number Description of Exhibit
−Removed: Amended and Restated Bylaws.
−Removed: Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K as filed with the SEC on September 5, 2024.
−Removed: Seventh Amendment to the Third Amended and Restated Credit Agreement, dated October 1 8, 2024 , by and among SAIC, Citibank N.A., as administrative agent and collateral agent, and certain other lenders and parties thereto.
−Removed: Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on October 22 , 2024 .
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
9 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: December 5, 2024
Science Applications International Corporation
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.